{"id":42728,"date":"2022-01-01T10:33:25","date_gmt":"2022-01-01T15:33:25","guid":{"rendered":"https:\/\/sciencebusiness.technewslit.com\/?p=42728"},"modified":"2022-01-01T10:33:25","modified_gmt":"2022-01-01T15:33:25","slug":"infographic-biotech-index-returns-to-earth","status":"publish","type":"post","link":"https:\/\/technewslit.com\/sciencebusiness\/?p=42728","title":{"rendered":"Infographic – Biotech Index Returns to Earth"},"content":{"rendered":"
\"Nasdaq<\/a>
Click on image for full-size view (Nasdaq)<\/figcaption><\/figure>\n

1 Jan. 2022. As 2022 begins, it’s time to review the Nasdaq Biotechnology Index for 2021, an indicator of investor sentiment in an industry based on scientific research. When we last looked at NBI<\/a> in early October 2021, the index began to dip in late September, which turned into steady decline into December.<\/p>\n

NBI opened on 4 Jan. 2021 at 4759.14, then rose sharply through January. In early February, however, the index fell sharply, then fluctuated around the 4750 mark until mid-May. At that point, NBI began an upward trend reaching 5496.19 on 9 Aug., its high point for the year. In the next six weeks, the index largely fluctuated between 5200 and 5400.<\/p>\n

After 23 Sept, NBI headed south, falling to 4523.82 on 6 Dec. That decline in the index from its peak on 9 Aug. to its close on 6 Dec. represents a loss of 18 percent. Since 6 Dec., NBI rose modestly to its close yesterday at 4728.94. For 2021, NBI ended up almost where it began, declining 0.6 percent. By comparison, the Nasdaq Composite Index<\/a>, an indicator of investor sentiment for the broader technology sector, rose 21 percent for the year.<\/p>\n

More from Science & Enterprise:<\/p>\n